Evidence map›Paper›PMID 28225045›Full record

ArticleScientific reports2017

Membrane targeting of TIRAP is negatively regulated by phosphorylation in its phosphoinositide-binding motif.

Xiaolin Zhao, Wen Xiong, Shuyan Xiao, Tuo-Xian Tang, Jeffrey F Ellena, Geoffrey S Armstrong, Carla V Finkielstein, Daniel G S Capelluto

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Knockdown of Transmembrane Protein 150A (Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2022
    Article
  8. Review
  9. TIRAP in the Mechanism of Inflammation.Frontiers in immunology · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Solution structure of the TLR adaptor MAL/TIRAP reveals an intact BB loop and supports MAL Cys91 glutathionylation for signaling.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Xiaolin ZhaoProtein Signaling Domains Laboratory, Department of Biological Sciences, Biocomplexity Institute, and Center for Soft Matter and Biological Physics, Virginia Tech, Blacksburg VA, 24061, USA.
Wen XiongProtein Signaling Domains Laboratory, Department of Biological Sciences, Biocomplexity Institute, and Center for Soft Matter and Biological Physics, Virginia Tech, Blacksburg VA, 24061, USA.
Shuyan XiaoSchool of Materials and Metallurgy, Inner Mongolia University of Science and Technology, P. R. China.
Tuo-Xian TangProtein Signaling Domains Laboratory, Department of Biological Sciences, Biocomplexity Institute, and Center for Soft Matter and Biological Physics, Virginia Tech, Blacksburg VA, 24061, USA.
Jeffrey F EllenaBiomolecular Magnetic Resonance Facility, University of Virginia, Charlottesville VA, 22904, USA.
Geoffrey S ArmstrongDepartments of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder CO, 80309, USA.
Carla V FinkielsteinIntegrated Cellular Responses Laboratory, Department of Biological Sciences, Biocomplexity Institute, Virginia Tech, Blacksburg VA, 24061, USA.
Daniel G S CapellutoProtein Signaling Domains Laboratory, Department of Biological Sciences, Biocomplexity Institute, and Center for Soft Matter and Biological Physics, Virginia Tech, Blacksburg VA, 24061, USA.
Virginia Tech · USInner Mongolia University of Technology · CNUniversity of Colorado Boulder · USUniversity of Virginia · US

Funding

800 MHZ NMR SPECTROMETER FOR HIGH-END NMR STRUCTURAL STUDIES: AIDSS10RR023035 · NCRR · UNIVERSITY OF VIRGINIA · PI BUSHWELLER, JOHN HACKETT · 2006 to 2006
$2.0M
Molecular mechanism of TIRAP membrane targetingR03AI108978 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI CAPELLUTO, DANIEL GUILLERMO · 2014 to 2015
$161k
NCRR NIH HHS S10 RR023035NIAID NIH HHS R03 AI108978
6 · The paper itself

Abstract

Pathogen-activated Toll-like receptors (TLRs), such as TLR2 and TLR4, dimerize and move laterally across the plasma membrane to phosphatidylinositol (4,5)-bisphosphate-enriched domains. At these sites, TLRs interact with the TIR domain-containing adaptor protein (TIRAP), triggering a signaling cascade that leads to innate immune responses. Membrane recruitment of TIRAP is mediated by its phosphoinositide (PI)-binding motif (PBM). We show that TIRAP PBM transitions from a disordered to a helical conformation in the presence of either zwitterionic micelles or monodispersed PIs. TIRAP PBM bound PIs through basic and nonpolar residues with high affinity, favoring a more ordered structure. TIRAP is phosphorylated at Thr28 within its PBM, which leads to its ubiquitination and degradation. We demonstrate that phosphorylation distorts the helical structure of TIRAP PBM, reducing PI interactions and cell membrane targeting. Our study provides the basis for TIRAP membrane insertion and the mechanism by which it is removed from membranes to avoid sustained innate immune responses.

Indexed as

Protein Processing, Post-TranslationalBinding SitesCell MembraneHEK293 CellsHumansMembrane GlycoproteinsPhosphatidylinositolsPhosphorylationProtein BindingProtein ConformationProtein TransportProteolysisReceptors, Interleukin-1UbiquitinationMembrane GlycoproteinsPhosphatidylinositolsReceptors, Interleukin-1TIRAP protein, human

Identifiers

PMID28225045
PMCPMC5320522
OpenAlexW2589751962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.